site stats

Dr reddy's sec filings

WebJul 1, 2024 · June 30, 2024 11:58 PM Eastern Daylight Time. HYDERABAD, India-- ( BUSINESS WIRE )--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ... WebSep 8, 2024 · RDY / Dr. Reddy's Laboratories Ltd. (Current Report of Foreign Issuer) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 January 2024 Commission File …

Bristol Myers Squibb - Bristol Myers Squibb Announces Settlement …

WebJun 11, 2024 · Risks that could affect our future operating results are described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2024. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking ... WebJul 1, 2024 · June 30, 2024 11:58 PM Eastern Daylight Time. HYDERABAD, India-- ( BUSINESS WIRE )--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, … marketwatch eli lilly https://yangconsultant.com

Dr. Reddy’s Laboratories Limited announces filing of Annual …

WebSep 17, 2024 · Dr. Reddy’s licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March 2024 date previously granted to Natco Dr. Reddy’s also licensed to sell generic lenalidomide in the U.S. without volume limitation beginning on January 31, 2026 The earliest licensed entry of any generic … WebDr. Reddy’s announces ANDA filing for Olanzapine ODT. Hyderabad, India, March 11 2003: Dr. Reddy’s Laboratories (NYSE: RDY) today announced that the Company had filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Olanzapine Orally Disintegrating Tablets (ODT), equivalent to 5mg, 10mg, 15mg and … WebDr. Reddy's Laboratories Ltd. ADR SEC filings breakout by MarketWatch. View the RDY U.S. Securities and Exchange Commission reporting information. marketwatch epr

Press Releases - Dr. Reddy

Category:Form 6-K DR REDDYS LABORATORIES For: Feb 21

Tags:Dr reddy's sec filings

Dr reddy's sec filings

Citius Pharmaceuticals Acquires Dr. Reddy

WebMar 28, 2024 · Sequoia Financial Advisors LLC lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 118.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,531 shares of the co WebFeb 19, 2024 · SEC Filings. Form 6-K DR REDDYS LABORATORIES For: Feb 19. Article Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! E-mail Address.

Dr reddy's sec filings

Did you know?

WebMar 1, 2024 · Dimensional Fund Advisors LP increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 9.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 836,937 shares of the company's stock WebDr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.

WebJul 31, 2024 · SEC Filings. Form 6-K DR REDDYS LABORATORIES For: Sep 16. Article Stock Quotes (1) FREE Breaking News Alerts from StreetInsider.com! E-mail Address. WebJul 27, 2024 · Shares of Dr Reddy’s Laboratories Ltd fell more than 10% on Tuesday, thanks to a subpoena from the US SEC (Securities and Exchange Commission) and slightly weaker-than-expected June-quarter results.

Web2005. 2001. Pre. May. Earnings Release - Q4 FY22. Apr. Dr. Reddy's Laboratories announces the launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market. Dr. Reddy's Laboratories announces the launch of Methylprednisolone. Dr. Reddy's Laboratories and MediCane Health announce the launch of medical cannabis … WebVarious SEC filing data available including balance sheets, cash flows and more. Central Index Key (CIK) and ticker conversions for looking up companies. Obtain spreadsheets …

WebFeb 22, 2024 · securities and exchange commission. washington, d.c. 20549 . form 6-k . report of foreign private issuer pursuant to rule 13a-16 or 15d-16. under the securities exchange act of 1934

WebMar 28, 2024 · Dr. Reddy's Laboratories Trading Up 0.8 %. Shares of Dr. Reddy's Laboratories stock opened at $55.24 on Tuesday. Dr. Reddy's Laboratories Limited has … market watch eli lillyWebDR. REDDY'S LABORATORIES LTD. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500034. Telangana, India. ... Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F Hyderabad, India, June 16, 2024 For Immediate Release ... accessed by selecting ‘SEC filings’ under ‘Reports and Filings’ section under ‘Investors ... marketwatch emrWebMar 24, 2024 · Assenagon Asset Management S.A. increased its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 210.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 196,038 shares of the company's stock af navitus health secondarymarketwatch ericssonWebSep 8, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR … marketwatch email newsletterWebFiling Detail. SEC Home » Search the Next-Generation EDGAR System » Company Search » Current Page; Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC … navitus health insurance phone numberWebJan 24, 2024 · Find the latest Dr. Reddy's Laboratories Limited (RDY) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. navitus health solutions career